Ionis Pharmaceuticals plans to double its current real estate footprint with a new biotech manufacturing facility in Oceanside, California, among the latest signs of rising life science real estate demand in the San Diego region and other hubs of the fast-growing industry.
Biotech Firm Plans to Double Footprint in San Diego Suburb
Ionis Pharmaceuticals’ Oceanside Project Arrives With U.S. Life Science Demand Rising Despite Tough Economy
By Lou Hirsh
CoStar News
October 13, 2022 | 11:43 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Companies
- Ionis Pharmaceuticals, Inc.
Manufacturing